Core Viewpoint - The article emphasizes the need to strengthen the construction of a smart medical network system, focusing on remote medical monitoring and establishing a regular dual-heart (cardiac and psychological) health check mechanism [1] Group 1: Recommendations for Healthcare Improvement - Liu Meiyan, a member of the Beijing Municipal Political Consultative Conference, suggests enhancing the dual-heart medical discipline and establishing a disease database based on cardiac ultrasound and electrocardiogram data to study disease mechanisms [1] - The proposal includes the development of a risk assessment system to provide remote consultation and psychological counseling for individuals at health risk, leading to personalized treatment plans [1] Group 2: Interdisciplinary Collaboration - The article advocates for the integration of resources in Beijing to connect cardiovascular, mental health, endocrine, and sleep disciplines, promoting the establishment of dual-heart outpatient services and wards in hospitals [1]

Core Viewpoint - Microelectrophysiology announced the transfer of 36.3636% equity in its associate company Shanghai Yuanchin Medical Technology Co., Ltd. to Shanghai Mohua Artificial Intelligence Technology Co., Ltd. for a transaction price of RMB 5 million, after which the company will no longer hold shares in Shanghai Yuanchin [1][6] Company Overview - Microelectrophysiology was established on August 31, 2010, in the Shanghai International Medical Park, focusing on innovative medical device research, production, and sales in the field of electrophysiological intervention and ablation therapy [3][8] - The company aims to provide globally competitive integrated solutions for diagnosis and ablation therapy centered on precise interventional navigation, having completed a comprehensive product layout covering cardiac electrophysiology surgery [3][8] Financial Performance of Shanghai Yuanchin - Shanghai Yuanchin has invested over RMB 40 million in R&D and holds multiple patents and product registration certificates, but has been in a continuous loss state due to challenges in hospital promotion and intense market competition [4][9] - The projected net loss for Shanghai Yuanchin is RMB 4.594 million for 2024, and RMB 2.9725 million for the period from January to October 2025, with a net asset value of -RMB 8.0792 million as of October 31, 2025 [4][9] Strategic Intent - The transfer of shares is aimed at optimizing the asset structure and focusing on core business areas, with Shanghai Mohua's business highly compatible with Shanghai Yuanchin's technology services and software development, potentially providing industrial resource empowerment [5][10]